US Stock MarketDetailed Quotes

IKT Inhibikase Therapeutics

Watchlist
  • 3.2000
  • +0.0400+1.27%
Close Dec 20 16:00 ET
  • 3.2700
  • +0.0700+2.19%
Post 20:01 ET
215.02MMarket Cap-1.03P/E (TTM)

Inhibikase Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Inhibikase Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
Aug 14, 20242024/Q20.000 / 0.000--
May 16, 20242024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
Aug 14, 20242024/Q20.000 / 0.000--
May 16, 20242024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Inhibikase Therapeutics Earnings Reports

  • Inhibikase Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 14 08:37 ET

  • Inhibikase Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 14 16:20 ET

  • Inhibikase Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 15 17:11 ET

  • Inhibikase Therapeutics | 10-K: FY2023 Annual Report

    Mar 27 16:12 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 30, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data